Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...

Vancomycin is the first-choice treatment for MRSA-infected newborns; studies on efficacy of mupirocin for patient decolonization show controversial results. The impact of MRSA infections in NICU ...

In addition, the relatively short follow-up makes it impossible to determine if treatment had an impact ... and with increasing MRSA infections it is a concern as to how effective these agents ...

MRSA: The Spread of Drug Resistance In fact ... was developed in the 1950s as an alternative treatment for the growing proportion of staph infections already resistant to penicillin.

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

approved Zevtera for three specific treatment indications, and it is the only FDA-approved methicillin-resistant Staphylococcus aureus (MRSA) cephalosporin antibiotic for treating adult patients ...

They kill around 700,000 people a year, and new treatments are urgently needed ... They tested the compound on rats that they had given MRSA and it eliminated the infection in skin wounds.